Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
Cardiac ischemia and ischemia/reperfusion cause wide proteolysis of the coronary endothelial luminal membrane: possible dysfunctions.

The open cardiovascular medicine journal

Arroyo-Flores B, Chi-Ahumada E, Briones-Cerecero E, Barajas-Espinosa A, Perez-Aguilar S, de la Rosa AB, Knabb M, Rubio R.
PMID: 22262983
Open Cardiovasc Med J. 2011;5:239-45. doi: 10.2174/1874192401105010239. Epub 2011 Dec 30.

BACKGROUND: Ischemia and ischemia-reperfusion (I/R) are common clinical insults that disrupt the molecular structure of coronary vascular endothelial luminal membrane (VELM) that result in diverse microvasculature dysfunctions. However, the knowledge of the associated biochemical changes is meager. We hypothesized...

Cite
Arroyo-Flores B, Chi-Ahumada E, Briones-Cerecero E, et al. Cardiac ischemia and ischemia/reperfusion cause wide proteolysis of the coronary endothelial luminal membrane: possible dysfunctions. Open Cardiovasc Med J. 2011;5:239-45doi: 10.2174/1874192401105010239.
Arroyo-Flores, B., Chi-Ahumada, E., Briones-Cerecero, E., Barajas-Espinosa, A., Perez-Aguilar, S., de la Rosa, A. B., Knabb, M., & Rubio, R. (2011). Cardiac ischemia and ischemia/reperfusion cause wide proteolysis of the coronary endothelial luminal membrane: possible dysfunctions. The open cardiovascular medicine journal, 5239-45. https://doi.org/10.2174/1874192401105010239
Arroyo-Flores, Blanca, et al. "Cardiac ischemia and ischemia/reperfusion cause wide proteolysis of the coronary endothelial luminal membrane: possible dysfunctions." The open cardiovascular medicine journal vol. 5 (2011): 239-45. doi: https://doi.org/10.2174/1874192401105010239
Arroyo-Flores B, Chi-Ahumada E, Briones-Cerecero E, Barajas-Espinosa A, Perez-Aguilar S, de la Rosa AB, Knabb M, Rubio R. Cardiac ischemia and ischemia/reperfusion cause wide proteolysis of the coronary endothelial luminal membrane: possible dysfunctions. Open Cardiovasc Med J. 2011;5:239-45. doi: 10.2174/1874192401105010239. Epub 2011 Dec 30. PMID: 22262983; PMCID: PMC3258568.
Copy Download .nbib Format: NLM
Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis.

JCI insight

Czauderna C, Poplawski A, O'Rourke CJ, Castven D, Pérez-Aguilar B, Becker D, Heilmann-Heimbach S, Odenthal M, Amer W, Schmiel M, Drebber U, Binder H, Ridder DA, Schindeldecker M, Straub BK, Galle PR, Andersen JB, Thorgeirsson SS, Park YN, Marquardt JU.
PMID: 34375307
JCI Insight. 2021 Sep 08;6(17). doi: 10.1172/jci.insight.146196.

Development of primary liver cancer is a multistage process. Detailed understanding of sequential epigenetic alterations is largely missing. Here, we performed Infinium Human Methylation 450k BeadChips and RNA-Seq analyses for genome-wide methylome and transcriptome profiling of cirrhotic liver (n...

Cite
Czauderna C, Poplawski A, O'Rourke CJ, et al. Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis. JCI Insight. 2021;6(17)doi: 10.1172/jci.insight.146196.
Czauderna, C., Poplawski, A., O'Rourke, C. J., Castven, D., Pérez-Aguilar, B., Becker, D., Heilmann-Heimbach, S., Odenthal, M., Amer, W., Schmiel, M., Drebber, U., Binder, H., Ridder, D. A., Schindeldecker, M., Straub, B. K., Galle, P. R., Andersen, J. B., Thorgeirsson, S. S., Park, Y. N., & Marquardt, J. U. (2021). Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis. JCI insight, 6(17), . https://doi.org/10.1172/jci.insight.146196
Czauderna, Carolin, et al. "Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis." JCI insight vol. 6,17 (2021). doi: https://doi.org/10.1172/jci.insight.146196
Czauderna C, Poplawski A, O'Rourke CJ, Castven D, Pérez-Aguilar B, Becker D, Heilmann-Heimbach S, Odenthal M, Amer W, Schmiel M, Drebber U, Binder H, Ridder DA, Schindeldecker M, Straub BK, Galle PR, Andersen JB, Thorgeirsson SS, Park YN, Marquardt JU. Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis. JCI Insight. 2021 Sep 08;6(17). doi: 10.1172/jci.insight.146196. PMID: 34375307; PMCID: PMC8492348.
Copy Download .nbib Format: NLM
Heat conduction in systems with Kolmogorov-Arnold-Moser phase space structure.

Physical review. E, Statistical, nonlinear, and soft matter physics

Herrera-González IF, Pérez-Aguilar HI, Mendoza-Suárez A, Tututi ES.
PMID: 23030897
Phys Rev E Stat Nonlin Soft Matter Phys. 2012 Sep;86(3):031138. doi: 10.1103/PhysRevE.86.031138. Epub 2012 Sep 25.

We study heat conduction in a billiard channel formed by two sinusoidal walls and the diffusion of particles in the corresponding channel of infinite length; the latter system has an infinite horizon, i.e., a particle can travel an arbitrary...

Cite
Herrera-González IF, Pérez-Aguilar HI, Mendoza-Suárez A, et al. Heat conduction in systems with Kolmogorov-Arnold-Moser phase space structure. Phys Rev E Stat Nonlin Soft Matter Phys. 2012;86(3):031138doi: 10.1103/PhysRevE.86.031138.
Herrera-González, I. F., Pérez-Aguilar, H. I., Mendoza-Suárez, A., & Tututi, E. S. (2012). Heat conduction in systems with Kolmogorov-Arnold-Moser phase space structure. Physical review. E, Statistical, nonlinear, and soft matter physics, 86(3), 031138. https://doi.org/10.1103/PhysRevE.86.031138
Herrera-González, I F, et al. "Heat conduction in systems with Kolmogorov-Arnold-Moser phase space structure." Physical review. E, Statistical, nonlinear, and soft matter physics vol. 86,3 (2012): 031138. doi: https://doi.org/10.1103/PhysRevE.86.031138
Herrera-González IF, Pérez-Aguilar HI, Mendoza-Suárez A, Tututi ES. Heat conduction in systems with Kolmogorov-Arnold-Moser phase space structure. Phys Rev E Stat Nonlin Soft Matter Phys. 2012 Sep;86(3):031138. doi: 10.1103/PhysRevE.86.031138. Epub 2012 Sep 25. PMID: 23030897.
Copy Download .nbib Format: NLM
Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis.

JCI insight

Czauderna C, Poplawski A, O'Rourke CJ, Castven D, Pérez-Aguilar B, Becker D, Heilmann-Heimbach S, Odenthal M, Amer W, Schmiel M, Drebber U, Binder H, Ridder DA, Schindeldecker M, Straub BK, Galle PR, Andersen JB, Thorgeirsson SS, Park YN, Marquardt JU.
PMID: 34375307
JCI Insight. 2021 Sep 08;6(17). doi: 10.1172/jci.insight.146196.

Development of primary liver cancer is a multistage process. Detailed understanding of sequential epigenetic alterations is largely missing. Here, we performed Infinium Human Methylation 450k BeadChips and RNA-Seq analyses for genome-wide methylome and transcriptome profiling of cirrhotic liver (n...

Cite
Czauderna C, Poplawski A, O'Rourke CJ, et al. Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis. JCI Insight. 2021;6(17)doi: 10.1172/jci.insight.146196.
Czauderna, C., Poplawski, A., O'Rourke, C. J., Castven, D., Pérez-Aguilar, B., Becker, D., Heilmann-Heimbach, S., Odenthal, M., Amer, W., Schmiel, M., Drebber, U., Binder, H., Ridder, D. A., Schindeldecker, M., Straub, B. K., Galle, P. R., Andersen, J. B., Thorgeirsson, S. S., Park, Y. N., & Marquardt, J. U. (2021). Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis. JCI insight, 6(17), . https://doi.org/10.1172/jci.insight.146196
Czauderna, Carolin, et al. "Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis." JCI insight vol. 6,17 (2021). doi: https://doi.org/10.1172/jci.insight.146196
Czauderna C, Poplawski A, O'Rourke CJ, Castven D, Pérez-Aguilar B, Becker D, Heilmann-Heimbach S, Odenthal M, Amer W, Schmiel M, Drebber U, Binder H, Ridder DA, Schindeldecker M, Straub BK, Galle PR, Andersen JB, Thorgeirsson SS, Park YN, Marquardt JU. Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis. JCI Insight. 2021 Sep 08;6(17). doi: 10.1172/jci.insight.146196. PMID: 34375307; PMCID: PMC8492348.
Copy Download .nbib Format: NLM
Risk factors associated with thyroid nodular disease in acromegalic patients: A case-cohort study in a tertiary center.

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society

Vargas-Ortega G, Romero-Gameros CA, Rendón-Macias ME, Balcázar-Hernández L, Sosa-Eroza E, Mercado M, de Los Monteros-Sánchez ALE, Pérez-Aguilar B, Paredes-Manjarrez C, Reyes-Olhagaray FB, Serrano-Ramírez DL, la Cruz EVM, González-Virla B.
PMID: 34740022
Growth Horm IGF Res. 2021 Oct-Dec;60:101431. doi: 10.1016/j.ghir.2021.101431. Epub 2021 Oct 12.

INTRODUCTION: Goiter is very common in patients with acromegaly; its development is correlated to the duration of the disease. Thyroid cells express the IGF-1 receptor and the TSH/IGF-1 interaction has been demonstrated to have a synergistic effect in thyroid...

Cite
Vargas-Ortega G, Romero-Gameros CA, Rendón-Macias ME, et al. Risk factors associated with thyroid nodular disease in acromegalic patients: A case-cohort study in a tertiary center. Growth Horm IGF Res. 2021;60:101431doi: 10.1016/j.ghir.2021.101431.
Vargas-Ortega, G., Romero-Gameros, C. A., Rendón-Macias, M. E., Balcázar-Hernández, L., Sosa-Eroza, E., Mercado, M., de Los Monteros-Sánchez, A. L. E., Pérez-Aguilar, B., Paredes-Manjarrez, C., Reyes-Olhagaray, F. B., Serrano-Ramírez, D. L., la Cruz, E. V. M., & González-Virla, B. (2021). Risk factors associated with thyroid nodular disease in acromegalic patients: A case-cohort study in a tertiary center. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 60101431. https://doi.org/10.1016/j.ghir.2021.101431
Vargas-Ortega, Guadalupe, et al. "Risk factors associated with thyroid nodular disease in acromegalic patients: A case-cohort study in a tertiary center." Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society vol. 60 (2021): 101431. doi: https://doi.org/10.1016/j.ghir.2021.101431
Vargas-Ortega G, Romero-Gameros CA, Rendón-Macias ME, Balcázar-Hernández L, Sosa-Eroza E, Mercado M, de Los Monteros-Sánchez ALE, Pérez-Aguilar B, Paredes-Manjarrez C, Reyes-Olhagaray FB, Serrano-Ramírez DL, la Cruz EVM, González-Virla B. Risk factors associated with thyroid nodular disease in acromegalic patients: A case-cohort study in a tertiary center. Growth Horm IGF Res. 2021 Oct-Dec;60:101431. doi: 10.1016/j.ghir.2021.101431. Epub 2021 Oct 12. PMID: 34740022.
Copy Download .nbib Format: NLM
The Pd-catalyzed synthesis of benzofused carbo- and heterocycles through carbene migratory insertion/carbopalladation cascades with tosylhydrazones.

Chemical communications (Cambridge, England)

Paraja M, Pérez-Aguilar MC, Valdés C.
PMID: 26400071
Chem Commun (Camb). 2015 Nov 21;51(90):16241-3. doi: 10.1039/c5cc06348e.

The Pd-catalyzed reaction between o-iodoallylbenzene and tosylhydrazones gives rise to indene derivatives through a process that involves a carbene migratory insertion followed by an intramolecular carbopalladation, with the formation of two C-C bonds on the same carbon atom. The...

Cite
Paraja M, Pérez-Aguilar MC, Valdés C. The Pd-catalyzed synthesis of benzofused carbo- and heterocycles through carbene migratory insertion/carbopalladation cascades with tosylhydrazones. Chem Commun (Camb). 2015;51(90):16241-3doi: 10.1039/c5cc06348e.
Paraja, M., Pérez-Aguilar, M. C., & Valdés, C. (2015). The Pd-catalyzed synthesis of benzofused carbo- and heterocycles through carbene migratory insertion/carbopalladation cascades with tosylhydrazones. Chemical communications (Cambridge, England), 51(90), 16241-3. https://doi.org/10.1039/c5cc06348e
Paraja, Miguel, et al. "The Pd-catalyzed synthesis of benzofused carbo- and heterocycles through carbene migratory insertion/carbopalladation cascades with tosylhydrazones." Chemical communications (Cambridge, England) vol. 51,90 (2015): 16241-3. doi: https://doi.org/10.1039/c5cc06348e
Paraja M, Pérez-Aguilar MC, Valdés C. The Pd-catalyzed synthesis of benzofused carbo- and heterocycles through carbene migratory insertion/carbopalladation cascades with tosylhydrazones. Chem Commun (Camb). 2015 Nov 21;51(90):16241-3. doi: 10.1039/c5cc06348e. PMID: 26400071.
Copy Download .nbib Format: NLM
[Use of collagen-polyvinylpirrolidone in the treatment of Parry-Romberg syndrome.].

Revista medica del Instituto Mexicano del Seguro Social

Hernández-Vega GA, Ruiz-Eng R, Montiel-Jarquín A, Gómez-Conde E, López-Colombo A, Pérez-Aguilar A, Bejarano-Huertas R.
PMID: 24290024
Rev Med Inst Mex Seguro Soc. 2013 November-December;51(6):692-695.

Background: Parry-Romberg syndrome is characterized by the presence of progressive hemifacial atrophy that affects the growth and development of structures on one side of the face. Our objective was to introduce collagen-polyvinylpirrolidone as a new therapeutic option for Parry-Romberg...

Cite
Hernández-Vega GA, Ruiz-Eng R, Montiel-Jarquín A, et al. Colágeno-polivinilpirrolidona para tratar el síndrome de Parry-Romberg. [Use of collagen-polyvinylpirrolidone in the treatment of Parry-Romberg syndrome.]. Rev Med Inst Mex Seguro Soc. 2013;51(6):692-695
Hernández-Vega, G. A., Ruiz-Eng, R., Montiel-Jarquín, A., Gómez-Conde, E., López-Colombo, A., Pérez-Aguilar, A., & Bejarano-Huertas, R. (2013). Colágeno-polivinilpirrolidona para tratar el síndrome de Parry-Romberg. [Use of collagen-polyvinylpirrolidone in the treatment of Parry-Romberg syndrome.]. Revista medica del Instituto Mexicano del Seguro Social, 51(6), 692-695.
Hernández-Vega, Giovanni Ahmed, et al. "Colágeno-polivinilpirrolidona para tratar el síndrome de Parry-Romberg." [Use of collagen-polyvinylpirrolidone in the treatment of Parry-Romberg syndrome.]. Revista medica del Instituto Mexicano del Seguro Social vol. 51,6 (2013): 692-695.
Hernández-Vega GA, Ruiz-Eng R, Montiel-Jarquín A, Gómez-Conde E, López-Colombo A, Pérez-Aguilar A, Bejarano-Huertas R. Colágeno-polivinilpirrolidona para tratar el síndrome de Parry-Romberg. [Use of collagen-polyvinylpirrolidone in the treatment of Parry-Romberg syndrome.]. Rev Med Inst Mex Seguro Soc. 2013 November-December;51(6):692-695. Spanish. PMID: 24290024.
Copy Download .nbib Format: NLM
Olefination of carbonyl compounds through reductive coupling of alkenylboronic acids and tosylhydrazones.

Angewandte Chemie (International ed. in English)

Pérez-Aguilar MC, Valdés C.
PMID: 22639425
Angew Chem Int Ed Engl. 2012 Jun 11;51(24):5953-7. doi: 10.1002/anie.201200683. Epub 2012 May 25.

No abstract available.

Cite
Pérez-Aguilar MC, Valdés C. Olefination of carbonyl compounds through reductive coupling of alkenylboronic acids and tosylhydrazones. Angew Chem Int Ed Engl. 2012;51(24):5953-7doi: 10.1002/anie.201200683.
Pérez-Aguilar, M. C., & Valdés, C. (2012). Olefination of carbonyl compounds through reductive coupling of alkenylboronic acids and tosylhydrazones. Angewandte Chemie (International ed. in English), 51(24), 5953-7. https://doi.org/10.1002/anie.201200683
Pérez-Aguilar, M Carmen, and Valdés, Carlos. "Olefination of carbonyl compounds through reductive coupling of alkenylboronic acids and tosylhydrazones." Angewandte Chemie (International ed. in English) vol. 51,24 (2012): 5953-7. doi: https://doi.org/10.1002/anie.201200683
Pérez-Aguilar MC, Valdés C. Olefination of carbonyl compounds through reductive coupling of alkenylboronic acids and tosylhydrazones. Angew Chem Int Ed Engl. 2012 Jun 11;51(24):5953-7. doi: 10.1002/anie.201200683. Epub 2012 May 25. PMID: 22639425.
Copy Download .nbib Format: NLM
Peripheral blood eosinophilia as a marker of acute cellular rejection in lung transplant recipients.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Aguado Ibáñez S, Pérez Aguilar M, Royuela Vicente A, López García-Gallo C, Díaz Nuevo G, Salas Antón C, Ussetti Gil MP.
PMID: 35031205
J Heart Lung Transplant. 2021 Dec 22; doi: 10.1016/j.healun.2021.12.007. Epub 2021 Dec 22.

Previous studies in solid organ transplantation have shown a relationship between circulating eosinophil (EOS) counts and the presence of acute cellular rejection (ACR). However, the relationship between this potential biomarker and ACR in lung transplant (LTx) patients remains unclear.OBJECTIVE:...

Cite
Aguado Ibáñez S, Pérez Aguilar M, Royuela Vicente A, et al. Peripheral blood eosinophilia as a marker of acute cellular rejection in lung transplant recipients. J Heart Lung Transplant. 2021;doi: 10.1016/j.healun.2021.12.007.
Aguado Ibáñez, S., Pérez Aguilar, M., Royuela Vicente, A., López García-Gallo, C., Díaz Nuevo, G., Salas Antón, C., & Ussetti Gil, M. P. (2021). Peripheral blood eosinophilia as a marker of acute cellular rejection in lung transplant recipients. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, . https://doi.org/10.1016/j.healun.2021.12.007
Aguado Ibáñez, Silvia, et al. "Peripheral blood eosinophilia as a marker of acute cellular rejection in lung transplant recipients." The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation vol. (2021). doi: https://doi.org/10.1016/j.healun.2021.12.007
Aguado Ibáñez S, Pérez Aguilar M, Royuela Vicente A, López García-Gallo C, Díaz Nuevo G, Salas Antón C, Ussetti Gil MP. Peripheral blood eosinophilia as a marker of acute cellular rejection in lung transplant recipients. J Heart Lung Transplant. 2021 Dec 22; doi: 10.1016/j.healun.2021.12.007. Epub 2021 Dec 22. PMID: 35031205.
Copy Download .nbib Format: NLM
Stereoselective Csp(3) -Csp(2) Bond-Forming Reactions by Transition-Metal-Free Reductive Coupling of Cyclic Tosylhydrazones with Boronic Acids.

Chemistry (Weinheim an der Bergstrasse, Germany)

Plaza M, Pérez-Aguilar MC, Valdés C.
PMID: 26918955
Chemistry. 2016 Apr 25;22(18):6253-7. doi: 10.1002/chem.201600837. Epub 2016 Mar 21.

The reactions between alkenylboronic acids and tosylhydrazones derived from substituted cyclohexanones lead to the construction of disubstituted cyclohexanes with total regio- and stereoselectivity. In these transition-metal-free processes, a Csp(3) -Csp(2) and Csp(3) -H bond are formed on the same...

Cite
Plaza M, Pérez-Aguilar MC, Valdés C. Stereoselective Csp(3) -Csp(2) Bond-Forming Reactions by Transition-Metal-Free Reductive Coupling of Cyclic Tosylhydrazones with Boronic Acids. Chemistry. 2016;22(18):6253-7doi: 10.1002/chem.201600837.
Plaza, M., Pérez-Aguilar, M. C., & Valdés, C. (2016). Stereoselective Csp(3) -Csp(2) Bond-Forming Reactions by Transition-Metal-Free Reductive Coupling of Cyclic Tosylhydrazones with Boronic Acids. Chemistry (Weinheim an der Bergstrasse, Germany), 22(18), 6253-7. https://doi.org/10.1002/chem.201600837
Plaza, Manuel, et al. "Stereoselective Csp(3) -Csp(2) Bond-Forming Reactions by Transition-Metal-Free Reductive Coupling of Cyclic Tosylhydrazones with Boronic Acids." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 22,18 (2016): 6253-7. doi: https://doi.org/10.1002/chem.201600837
Plaza M, Pérez-Aguilar MC, Valdés C. Stereoselective Csp(3) -Csp(2) Bond-Forming Reactions by Transition-Metal-Free Reductive Coupling of Cyclic Tosylhydrazones with Boronic Acids. Chemistry. 2016 Apr 25;22(18):6253-7. doi: 10.1002/chem.201600837. Epub 2016 Mar 21. PMID: 26918955.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries